To achieve this objective, we investigated whether AIF-1 expression in tumor tissue samples from patients with NSCLC was associated with CD68 expression (a marker of monocytes such as macrophages), IL-6 expression, VEGF expression and clinicopathological features of aggressive tumor behavior. The gene discussed is IL6; the disease is neoplasm.